Improved prospects for long-term survival in adults with acute myelogenous leukemia
- 19 November 1982
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 248 (19), 2481-2486
- https://doi.org/10.1001/jama.248.19.2481
Abstract
Research from JAMA — Improved Prospects for Long-term Survival in Adults With Acute Myelogenous LeukemiaThis publication has 18 references indexed in Scilit:
- Beneficial Effects of Hepatitis in Patients with Acute Myelogenous LeukemiaAnnals of Internal Medicine, 1979
- Long-term survival in acute leukemia in Argentina.A study of 78 casesCancer, 1977
- PROLONGED MAINTAINED REMISSIONS OF ADULT ACUTE NON-LYMPHOCYTIC LEUKAEMIAThe Lancet, 1977
- HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIAThe Lancet, 1977
- PHASE 1 AND 2 TRIAL OF RUBIDAZONE IN PATIENTS WITH ACUTE-LEUKEMIA1977
- ADRIAMYCIN THERAPY IN PREVIOUSLY TREATED ADULT ACUTE-LEUKEMIA1977
- EVIDENCE FOR DIFFERENTIATION OF HUMAN LEUKEMIC BLOOD-CELLS IN DIFFUSION CHAMBER CULTURE1977
- Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapyJAMA, 1976
- Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignanciesCancer, 1976
- A study of the natural history of acute leukemia with special reference to the duration of the disease and the occurrence of remissionsCancer, 1951